Category Archives: News

Southlake, Texas, Sept. 08, 2022 — Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an ECG’s clinical usefulness by detecting cardiac dysfunction, today announced that Andrew Simpson, […]

Study Warns of Significant Increases in Diabetes and Cardiovascular Disease by 2060 Mohebi R, Chen C, Ibrahim N, et al. Cardiovascular Disease Projections in the United States Based on the 2020 Census Estimates. J Am Coll Cardiol. 2022 Aug, 80 (6) 565–578.https://doi.org/10.1016/j.jacc.2022.05.033 Using data from the 2020 US Census report and recent NHANES survey data, […]

MyoVista FDA De Novo Resubmission Expected in Current Fiscal Year Completed IPO in June 2022 with Approximately $6.375M of Gross Proceeds Listed on NASDAQ Capital Market under Ticker HSCS Southlake, Texas, August 1, 2022 (GLOBE NEWSWIRE) – Heart Test Laboratories, Inc. d/b/a HeartSciences (NASDAQ: HSCS; HSCSW)  (“HeartSciences” or the “Company”), a medical technology company focused on applying […]

Southlake, Texas, July 13, 2022 (GLOBE NEWSWIRE) — HeartSciences (NASDAQ: HSCS; HSCSW) (“Company”), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to significantly expand and improve an ECG’s clinical usefulness, today announced that Andrew Simpson, CEO, and Chairman of HeartSciences, will be participating in the […]

SOUTHLAKE, Texas, June 15, 2022 — Heart Test Laboratories, Inc. (NASDAQ: HSCS; HSCSW) (“HeartSciences” or the “Company”), a medical technology company focused on applying innovative AI-based technology to an ECG (also known as an EKG) to expand and improve an ECG’s clinical usefulness, today announced the pricing of its initial public offering of 1,500,000 units, […]